Profitability
Weight: 25%
C+
59
- 5yr Avg ROIC 6.8%
- Operating Margin Trend +1.57 pp/yr
BMY
Bristol-Myers Squibb Company
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
Capital Efficiency
Weight: 15%
B
70
- 5yr Avg ROE 10.1%
- 5yr Share-Count CAGR -2.0%
Growth Quality
Weight: 25%
D+
41
- 5yr Revenue CAGR 2.5%
- Revenue-Growth Years (5) 2/5
Cash Generation
Weight: 20%
A
92
- 5yr FCF Margin 28.5%
- 5yr FCF/NI Conversion 1.87x
Balance Sheet
Weight: 10%
B-
62
- Net Debt / EBITDA 2.39x
- Interest Coverage (EBIT/Int) 5.93x
- Altman Z-Score 2.43
Stability
Weight: 5%
C
54
- EPS Volatility (σ/μ) 0.44
- Negative-Revenue Years (5) 3/5
- Piotroski F-Score 8
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.3 of 4 gurus held; 3 added; 1 full exit.
- Holders
- 3 -1
- Avg Δ position
- +49.6%
- New buys
- 0
- Full exits
- 1